| 1 |
Kelley AS, Mcgarry K, Gorges R, et al. The burden of health care costs for patients with dementia in the last 5 years of life[J]. Annals of Internal Medicine, 2015, 163(10): 729-736.
|
| 2 |
阿尔茨海默病中医诊疗联合共识小组. 阿尔茨海默病的中医诊疗共识[J]. 中国中西医结合杂志，2018，38(5)：523-529.
|
| 3 |
程蕊，李玺，王娟，等．载脂蛋白E基因多态性与阿尔茨海默病相关性的Meta分析[J]．实用老年医学，2018，32(3)：263-267.
|
| 4 |
Mahley R. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology[J]. Science, 1988，240(4852)：622-630.
|
| 5 |
Yamazaki Y, Zhao N, Caulfield TR, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies[J]．Nat Rev Neurol, 2019，15(9)：501-518.
|
| 6 |
Casey CS, Atagi Y, Yamazaki Y, et al. Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway[J]. J Biol Chem, 2015，290(22)：14208-14217.
|
| 7 |
Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer’s disease[J]. Proc Natl Acad Sci USA，2010，107(22)：10256-10261.
|
| 8 |
Ossenkoppele R, Cohn-Sheehy BI, La Joie R, et al. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer′s disease[J]. Hum Brain Mapp，2015，36(11)：4421-4437.
|
| 9 |
Gonneaud J, Arenaza-Urquijo EM, Fouquet M, et al. Relative effect of APOEε4 on neuroimaging biomarker changes across the lifespan[J]. Neurology, 2016，87(16)：1696-1703.
|
| 10 |
Serrano-Pozo A, Qian J, Monsell SE, et al. APOEε2 Is Associated With Milder Clinical and Pathological Alzheimer’s Disease[J]. Annals of Neurology, 2015，77(6)：917-929.
|
| 11 |
Hashimoto T, Serrano-Pozo A, Hori Y, et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide[J]. Journal of Neuroscience, 2012，32(43)：15181-15192.
|
| 12 |
Garai K, Verghese PB, Baban B, et al. The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation[J]. Biochemistry, 2014，53(40)：6323-6331.
|
| 13 |
Jiang T, Chang RC, Rosenmann H，et al. Advances in Alzheimer′s disease: from bench to bedside[J]．Biomed Res Int，2015：202676.
|
| 14 |
Ossenkoppele R, Schonhaut DR, Schöll M, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease[J]. Brain, 2016, 139(Pt 5)：1551-1567.
|
| 15 |
Farfel JM, Yu L, De Jager PL, et al. Association of APOE with tau-tangle pathology with and without beta-amyloid[J]. Neurobiology of Aging, 2016，37：19-25.
|
| 16 |
Shi Y, Yamada K, Liddelow SA, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy[J]. Nature, 2017，549(7673): 523-527.
|
| 17 |
Niklas M, Rik O, Ruben S, et al. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study[J]. Alzheimer′s Research & Therapy, 2018, 10(1)：77.
|
| 18 |
Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease[J]. Nature Reviews Neuroscience, 2015，16(6)：358-372.
|
| 19 |
Nazem A, Sankowski R, Bacher M, et al. Rodent models of neuroinflammation for Alzheimer’s disease[J]. J Neuroinflammation，2015，12：74.
|
| 20 |
Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response[J]. Neurobiology of aging, 2009, 30(9)：1350-1360.
|
| 21 |
Bonham LW, Desikan RS, Yokoyama JS. The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease[J]. Acta Neuropathologica Communications，2016，4(1)：65.
|
| 22 |
侯江淇，郭蕾，张俊龙. 阿尔茨海默病中医辨治探析[J]. 辽宁中医杂志，2017，44(2)：44- 46.
|
| 23 |
尹龙，田金洲，时晶. 阿尔茨海默病的中医病机探讨[J]. 吉林中医药，2011，31(6)：495- 497.
|
| 24 |
张学凯，时晶，倪敬年，等. 阿尔茨海默病证候级联假说探讨[J]. 中医杂志，2019，60(9)：741-744.
|
| 25 |
时晶，倪敬年，魏明清，等. 阿尔茨海默病证候变化与认知结局的关联性[J]. 北京中医药大学学报，2017，40(4)：339-343.
|
| 26 |
Young AI, Benonisdottir S, Przeworski M, et al. Deconstructing the sources of genotype-phenotype associations in humans[J]. Science，2019，365(6460)：1396-1400.
|
| 27 |
Baselmans BML, Jansen R, Ip HF, et al. Multivariate genome-wide analyses of the well-being spectrum[J]. Nat Genet, 2019，51(3)：445- 451.
|
| 28 |
梁逸强，王佑华，周端．心脑血管相关疾病中医证候与基因多态性相关性的研究进展[J]中华中医药学刊，2011, 29(2)：286-288.
|
| 29 |
姚雪婷，梅应兵，孙勤国，等．老年健忘中医证型分布规律及与ApoE基因相关性[J]．中国老年学杂志，2020, 40(6)：1281-1284.
|
| 30 |
武峻艳，王杰. 从中医证候谈载脂蛋白E与阿尔茨海默病的相关性[J]. 陕西中医，2019, 40(8)：1109-1111.
|
| 31 |
李建橡，马晓聪，郑景辉，等. 痰瘀证候与载脂蛋白E基因多态性的meta分析[C]. 第九次全国中西医结合诊断学术研讨会论文集，2015, 334-339.
|
| 32 |
宋剑南，陈杲. 论载脂蛋白E及其基因多态性与中医痰瘀证候的关系[J]. 中国中医基础医学杂志，2002, 8(12)：893- 895.
|
| 33 |
胡慧，王平，孔明望，等. 阿尔茨海默病模型大鼠Tau蛋白异常磷酸化表达及补肾化痰法的干预作用[J]. 时珍国医国药，2010，21(10)：2681-2683.
|
| 34 |
苏芮，韩振蕴，范吉平，等. "毒损脑络"理论在阿尔茨海默病中医研究领域中的意义[J]. 中医杂志，2011，52(16)：1370-1371.
|